01.03.2008 | Review article
Chemotherapy plus bevacizumab in the first-line treatment of non-small cell lung cancer: benefits, risks and limitations
Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2008
Einloggen, um Zugang zu erhaltenAnzeige